^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    CXCL11 elevation

    i
    Entrez ID:
    6373
    Related biomarkers:
    Others
    Associations

    News

    Trials
    over2years
    CXCL11 negatively regulated by MED19 favours antitumour immune infiltration in breast cancer. (PubMed, Cytokine)
    Collectively, CXCL11 promoted antitumour immunity and was regulated by MED19 in BRCA. Clarifying the prognostic value and underlying mechanism of CXCL11 in BRCA could provide a theoretical basis to find new diagnostic and therapeutic targets.
    Journal • BRCA Biomarker • IO biomarker
    |
    CXCL11 (C-X-C Motif Chemokine Ligand 11)
    |
    CXCL11 elevation